Literature DB >> 21857224

New animal models of cystic fibrosis: what are they teaching us?

Nicholas W Keiser1, John F Engelhardt.   

Abstract

PURPOSE OF REVIEW: Cystic fibrosis is the first human genetic disease to benefit from the directed engineering of three different species of animal models (mice, pigs, and ferrets). Recent studies on the cystic fibrosis pig and ferret models are providing new information about the pathophysiology of cystic fibrosis in various organ systems. Additionally, new conditional cystic fibrosis transmembrane conductance regulator (CFTR) knockout mice are teaching unexpected lessons about CFTR function in surprising cellular locations. Comparisons between these animal models and the human condition are key to dissecting the complexities of disease pathophysiology in cystic fibrosis. RECENT
FINDINGS: Cystic fibrosis pigs and ferrets have provided new models to study the spontaneous development of disease in the lung and pancreas, two organs that are largely spared overt spontaneous disease in cystic fibrosis mice. New cystic fibrosis mouse models are now interrogating CFTR functions involved in growth and inflammation at an organ-based level using conditional knockout technology. Together, these models are providing new insights on the human condition.
SUMMARY: Basic and clinical cystic fibrosis research will benefit greatly from the comparative pathophysiology of cystic fibrosis mice, pigs, and ferrets. Both similarities and differences between these three cystic fibrosis models will inform pathophysiologically important mechanisms of CFTR function in humans and aid in the development of both organ-specific and general therapies for cystic fibrosis.
© 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21857224      PMCID: PMC3596000          DOI: 10.1097/MCP.0b013e32834b14c9

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  50 in total

1.  Mucus secretion by single tracheal submucosal glands from normal and cystic fibrosis transmembrane conductance regulator knockout mice.

Authors:  Juan P Ianowski; Jae Young Choi; Jeffrey J Wine; John W Hanrahan
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

Review 2.  An overview of international literature from cystic fibrosis registries 2. Neonatal screening and nutrition/growth.

Authors:  Donatello Salvatore; Roberto Buzzetti; Ermanno Baldo; Maria Pia Forneris; Vincenzina Lucidi; Daniela Manunza; Italo Marinelli; Barbara Messore; Anna Silvia Neri; Valeria Raia; Maria Lucia Furnari; Gianni Mastella
Journal:  J Cyst Fibros       Date:  2009-12-02       Impact factor: 5.482

Review 3.  Nutrition management of pediatric patients who have cystic fibrosis.

Authors:  Suzanne H Michel; Asim Maqbool; Maria D Hanna; Maria Mascarenhas
Journal:  Pediatr Clin North Am       Date:  2009-10       Impact factor: 3.278

4.  Generation of a conditional null allele for Cftr in mice.

Authors:  Craig A Hodges; Calvin U Cotton; Mark R Palmert; Mitchell L Drumm
Journal:  Genesis       Date:  2008-10       Impact factor: 2.487

5.  Transgenic animals may help resolve a sticky situation in cystic fibrosis.

Authors:  Jonathan H Widdicombe
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

6.  cAMP-activated Ca2+ signaling is required for CFTR-mediated serous cell fluid secretion in porcine and human airways.

Authors:  Robert J Lee; J Kevin Foskett
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

7.  Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis.

Authors:  Xingshen Sun; Hongshu Sui; John T Fisher; Ziying Yan; Xiaoming Liu; Hyung-Ju Cho; Nam Soo Joo; Yulong Zhang; Weihong Zhou; Yaling Yi; Joann M Kinyon; Diana C Lei-Butters; Michelle A Griffin; Paul Naumann; Meihui Luo; Jill Ascher; Kai Wang; Timothy Frana; Jeffrey J Wine; David K Meyerholz; John F Engelhardt
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

8.  Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.

Authors:  David K Meyerholz; David A Stoltz; Alejandro A Pezzulo; Michael J Welsh
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

9.  Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice.

Authors:  Gregory S Harmon; Darren S Dumlao; Damian T Ng; Kim E Barrett; Edward A Dennis; Hui Dong; Christopher K Glass
Journal:  Nat Med       Date:  2010-02-14       Impact factor: 53.440

10.  Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth.

Authors:  David A Stoltz; David K Meyerholz; Alejandro A Pezzulo; Shyam Ramachandran; Mark P Rogan; Greg J Davis; Robert A Hanfland; Chris Wohlford-Lenane; Cassie L Dohrn; Jennifer A Bartlett; George A Nelson; Eugene H Chang; Peter J Taft; Paula S Ludwig; Mira Estin; Emma E Hornick; Janice L Launspach; Melissa Samuel; Tatiana Rokhlina; Philip H Karp; Lynda S Ostedgaard; Aliye Uc; Timothy D Starner; Alexander R Horswill; Kim A Brogden; Randall S Prather; Sandra S Richter; Joel Shilyansky; Paul B McCray; Joseph Zabner; Michael J Welsh
Journal:  Sci Transl Med       Date:  2010-04-28       Impact factor: 17.956

View more
  60 in total

1.  Postentry processing of recombinant adeno-associated virus type 1 and transduction of the ferret lung are altered by a factor in airway secretions.

Authors:  Ziying Yan; Xingshen Sun; Idil A Evans; Scott R Tyler; Yi Song; Xiaoming Liu; Hongshu Sui; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2013-09       Impact factor: 5.695

2.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

3.  Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets.

Authors:  Xingshen Sun; Alicia K Olivier; Yaling Yi; Christopher E Pope; Hillary S Hayden; Bo Liang; Hongshu Sui; Weihong Zhou; Kyle R Hager; Yulong Zhang; Xiaoming Liu; Ziying Yan; John T Fisher; Nicholas W Keiser; Yi Song; Scott R Tyler; J Adam Goeken; Joann M Kinyon; Matthew C Radey; Danielle Fligg; Xiaoyan Wang; Weiliang Xie; Thomas J Lynch; Paul M Kaminsky; Mitchell J Brittnacher; Samuel I Miller; Kalpaj Parekh; David K Meyerholz; Lucas R Hoffman; Timothy Frana; Zoe A Stewart; John F Engelhardt
Journal:  Am J Pathol       Date:  2014-03-15       Impact factor: 4.307

4.  Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.

Authors:  Nicholas W Keiser; Susan E Birket; Idil A Evans; Scott R Tyler; Adrianne K Crooke; Xingshen Sun; Weihong Zhou; Joseph R Nellis; Elizabeth K Stroebele; Kengyeh K Chu; Guillermo J Tearney; Mark J Stevens; J Kirk Harris; Steven M Rowe; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2015-06       Impact factor: 6.914

5.  Incretin dysfunction and hyperglycemia in cystic fibrosis: Role of acyl-ghrelin.

Authors:  Xingshen Sun; Yaling Yi; Bo Liang; Yu Yang; Nan He; Katie Larson Ode; Aliye Uc; Kai Wang; Katherine N Gibson-Corley; John F Engelhardt; Andrew W Norris
Journal:  J Cyst Fibros       Date:  2019-02-07       Impact factor: 5.482

Review 6.  Impact of gene editing on the study of cystic fibrosis.

Authors:  Patrick T Harrison; David J Sanz; Jennifer A Hollywood
Journal:  Hum Genet       Date:  2016-06-21       Impact factor: 4.132

Review 7.  Therapeutics based on stop codon readthrough.

Authors:  Kim M Keeling; Xiaojiao Xue; Gwen Gunn; David M Bedwell
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-18       Impact factor: 8.929

8.  Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.

Authors:  William R Hunt; Susu M Zughaier; Dana E Guentert; Melissa A Shenep; Michael Koval; Nael A McCarty; Jason M Hansen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

Review 9.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

Review 10.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.